<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02282748</url>
  </required_header>
  <id_info>
    <org_study_id>SNCTP 000000612</org_study_id>
    <nct_id>NCT02282748</nct_id>
  </id_info>
  <brief_title>Swiss Longitudinal Cohort</brief_title>
  <official_title>Swiss Longitudinal Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hypertension Excellence Centre Lucerne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hypertension Excellence Centre Lucerne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The planned research project is a prospective population-based cohort study, similar to the
      well-known Framingham study in the United States. So far, there is no similar research
      project in Switzerland.

      It is planned to examine of three Swiss municipalities. Recruitment in a first Swiss
      municipality (Lostallo/Cama GR) started 2014 and ended in 2019. Overall, 496 participants
      were recruited in this municipality. The five-year follow-up in this municipality started in
      2019. It is planned to start recruitment in a second Swiss municipality (Uznach SG) in 2020.

      The examinations embrace a broad spectrum of measurements (for details the investigators
      refer to the published study protocol).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">September 2034</completion_date>
  <primary_completion_date type="Anticipated">September 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular events</measure>
    <time_frame>10 years</time_frame>
    <description>Cardiovascular events (i.e. stroke, myocardial infarction) will be assessed using questionnaires and case records.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart function</measure>
    <time_frame>10 years</time_frame>
    <description>Heart function will be assessed using questionnaires for symptoms, clinical examination and measurement of electromechanical activation time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>10 years</time_frame>
    <description>Cognitive function will be assessed using validated instruments.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kidney function</measure>
    <time_frame>10 years</time_frame>
    <description>Kidney function will be assessed using laboratory measurements.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Autonomy</measure>
    <time_frame>10 years</time_frame>
    <description>Autonomy wil be assessed using validated instruments.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nursing home admission</measure>
    <time_frame>10 years</time_frame>
    <description>Nursing home admissions will be assessed using standardized questions.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Changes in cardiovascular risk factors</measure>
    <time_frame>10 years</time_frame>
    <description>Cardiovascular risk factors will be assessed using validated measurements.</description>
  </other_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Cardiovascular Risk Factors</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Population of four Swiss municipalities
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Resident of Cama GR, Lostallo GR, or Uznach SG

          -  Age ≥6 years (no upper age limit), for voluntary blood sample ≥18 years

          -  Willing to participate in long-term study

          -  Written informed consent (in participants ≥6 years and &lt;18 years signed by parents)

        Exclusion Criteria:

          -  No exclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Erne, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hypertension Excellence Centre Lucerne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andreas W Schoenenberger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Department of Geriatrics, University of Bern</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paolo Suter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Franco Muggli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Swiss Society of Hypertension</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Renate Schoenenberger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hypertension Excellence Centre Lucerne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre-Alexandre Krayenbühl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Linth Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paul Erne, MD</last_name>
    <email>paul.erne@erne-net.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andreas W Schoenenberger, MD</last_name>
    <email>Andreas.Schoenenberger@insel.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cama</name>
      <address>
        <city>Cama</city>
        <state>Graubünden</state>
        <zip>CH-6557</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franco Muggli, MD</last_name>
      <email>fmuggli@bluewin.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lostallo</name>
      <address>
        <city>Lostallo</city>
        <state>Graubünden</state>
        <zip>CH-6558</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franco Muggli, MD</last_name>
      <email>fmuggli@bluewin.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Linth Hospital</name>
      <address>
        <city>Uznach</city>
        <state>Saint Gallen</state>
        <zip>8730</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Alexandre Krayenbühl, MD</last_name>
      <phone>+41 (0)55 285 49 62</phone>
      <email>pierre-alexandre.krayenbuehl@spital-linth.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 29, 2014</study_first_submitted>
  <study_first_submitted_qc>October 31, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2014</study_first_posted>
  <last_update_submitted>February 14, 2020</last_update_submitted>
  <last_update_submitted_qc>February 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

